Expleo Solutions Limited has informed the Exchange about Investor Presentation
EXPLEOSOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Expleo Solutions filed its earnings presentation for Q4 FY25 and full year FY25 ended March 31, 2025. Q4 FY25 operating revenue was Rs 2,558 million, marginally down 0.7% QoQ and largely flat YoY. Adjusted EBITDA was Rs 400 million (margin 15.6%), down 8.3% QoQ from Rs 436 million but flat YoY. PAT however grew 22.7% QoQ to Rs 236 million and 60% YoY, aided by a forex gain, with Basic EPS at Rs 15.51. For FY25, operating revenue rose 6.2% to Rs 10,248 million, Adjusted EBITDA grew 11.7% to Rs 1,657 million with margin expanding 80bps to 16.2%, and PAT grew 15.4% to Rs 1,023 million (EPS Rs 66.52). Net cash position improved to Rs 2,294 million from Rs 1,840 million YoY. Revenue mix remains BFSI-heavy (~80%) with Europe as the largest geography (~48%).
Full-year FY25 shows healthy revenue, margin, and profit growth with a strengthening cash balance, but the sequential QoQ dip in Q4 revenue and EBITDA margin may concern short-term investors. Overall, the results are broadly positive for shareholders, though the QoQ softness in margins warrants close watching.